Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 65 entries
View as:

Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections

Phase: N/A Priority: Normal
NCT ID: NCT00426933 Org: User:
Start: 01/31/07 End: 09/30/07 Due: 09/30/08

Clinical Evaluation Of Alvimopan (SB767905) On Constipation And Related Symptoms Associated With Opioid

Phase: N/A Priority: Normal
NCT ID: NCT00331045 Org: User:
Start: 04/30/06 End: 12/31/06 Due: 12/31/07

Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication

Phase: N/A Priority: Normal
NCT ID: NCT00101998 Org: User:
Start: 10/01/03 End: 05/01/06 Due: 05/01/07

Alvimopan For The Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT00259922 Org: User:
Start: 08/31/05 End: - Due: -

Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01901328 Org: User:
Start: 04/07/13 End: 02/13/14 Due: 02/13/15

Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Phase: N/A Priority: Normal
NCT ID: NCT00055198 Org: User:
Start: 12/19/02 End: 01/26/04 Due: 01/26/05

Evaluation of the Efficacy and Safety of ADL5945 for the Treatment of Opioid-induced Constipation in Adults Taking Opioid Therapy for Chronic Noncancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT01207427 Org: User:
Start: 10/14/10 End: 06/28/11 Due: 06/28/12

Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee

Phase: N/A Priority: Normal
NCT ID: NCT00979953 Org: User:
Start: 10/31/09 End: 06/30/10 Due: 06/30/11

Study of CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-005)

Phase: N/A Priority: Normal
NCT ID: NCT01597505 Org: User:
Start: 05/16/12 End: 03/20/15 Due: 03/20/16

Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00603265 Org: User:
Start: 11/30/07 End: 08/31/08 Due: 08/31/09

Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)

Phase: N/A Priority: Normal
NCT ID: NCT01728376 Org: User:
Start: 11/29/12 End: 01/20/16 Due: 01/20/17

Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT00256932 Org: User:
Start: 08/31/05 End: 05/31/06 Due: 05/31/07

Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT01058642 Org: User:
Start: 01/31/10 End: 12/31/10 Due: 12/31/11

Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)

Phase: N/A Priority: Normal
NCT ID: NCT02070757 Org: User:
Start: 09/02/14 End: 06/06/18 Due: 06/06/19

Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01853982 Org: User:
Start: 06/14/13 End: 12/08/13 Due: 12/08/14

Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00888940 Org: User:
Start: 06/30/09 End: 01/31/10 Due: 01/31/11

Study to Evaluate Daptomycin Given During Dialysis and After Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT00882557 Org: User:
Start: 04/29/09 End: 07/17/09 Due: 07/17/10

Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting

Phase: N/A Priority: Normal
NCT ID: NCT01175707 Org: User:
Start: 07/15/10 End: 11/17/11 Due: 11/17/12

Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement

Phase: N/A Priority: Normal
NCT ID: NCT00448864 Org: User:
Start: 05/01/07 End: 08/01/08 Due: 08/01/09

Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00538694 Org: User:
Start: 10/31/00 End: 09/30/01 Due: 09/30/02

Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections

Phase: N/A Priority: Normal
NCT ID: NCT00102947 Org: User:
Start: 01/31/05 End: 11/30/06 Due: 11/30/07

The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01901341 Org: User:
Start: 07/02/13 End: 02/13/14 Due: 02/13/15

A Dose-ranging Safety and Efficacy Study of Ecallantide to Reduce Surgical Blood Loss Volume

Phase: N/A Priority: Normal
NCT ID: NCT00816023 Org: User:
Start: 03/31/09 End: 01/31/10 Due: 01/31/11

Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus

Phase: N/A Priority: Normal
NCT ID: NCT00093067 Org: User:
Start: 03/31/02 End: 02/28/05 Due: 02/28/06

Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)

Phase: N/A Priority: Normal
NCT ID: NCT01922011 Org: User:
Start: 09/13/13 End: 12/20/16 Due: 12/20/17